Jorge Moll Has Recently Revealed Groundbreaking Research Regarding The Benefit That Humans Receive From The Act Of Giving To Others:

Neurologist Jorge Moll, MD, PhD serves as President-Director as well as a member of the Board of Directors for the D’Or Institute for Research and Education based out of Rio De Janiero, Brazil. He is also the head of the unit for Cognitive and Behavioral Neuroscience at the institute. Jorge is a graduate of the medical school at the Federal University of Rio De Janiero and did his residency at that facility as well.


Jorge Moll is noted for his work in the field of psychology as well as doing research regarding how neural mechanisms influence the choices that humans make. He has numerous publications to his credit that deal with this field and include topics such as moral cognition, values, sensitivity and emotions. Jorge has also worked closely with other leading neuroscience researchers including Roland Zahn, Ricardo Oliveira Souza and Jordan Grafman.


Jorge Moll recently opened up about some of his innovative new research in regard to the interplay between a person’s overall feeling of wellness and relationships. The basis of this research is the revelation that humans are essentially programmed to get a higher degree of pleasure out of giving back to other than the pleasure that is received from getting something from another person.


Depression is becoming an ever more present issue in human society and the suggestion is that a large part of this is due to the breakdown in human relationships and interactions that have become more prevalent in modern society. What Jorge Moll has discovered in his extensive research is the fact that the real key to overcoming issues related to depression is to have quality relationships in your life. His research has specifically focused on the reactions the brain has to emotional feelings as well as to acts that fall within an altruistic and ethical sphere. The end result that Jorge Moll’s research has yielded is that it appears that pleasure arises within humans by the act of doing things for others. These results show that the brains reward systems give far more pleasure to a person from the act of giving rather than receiving. Jorge’s research further shows that this act of giving in conjunction with close relationships plays a huge role in a person’s overall well being.


Jeff Aronin’s passion for pharmaceuticals got ignited while following a medical practitioner treating a young epileptic patient. The only option the doctor had was to remove part of the patient’s brain, but he applied a different method of treatment that controlled his seizures. The doctor was able to evade the life-changing surgery and at the same time lining Jeff Aronin’s biopharmaceutical entrepreneurship career.


Jeff Aronin has an M.B.A from DePaul University and a Bachelor of Surgery degree from Northern Illinois University. He is also an entrepreneurship lecturer in University of Chicago Booth of Business and Northwestern University’s Kellogg School of Management the place he did his postgraduate in 2010. There he got named an Aspen Institute Henry Crown Fellow.


After his studies, Jeff worked in health care, so he made his move to become a founder and CEO of Ovation Pharmaceuticals LLC in 2000. Jeff Aronin felt the need to do more for the patients whose medical needs aren’t met and or the ones with rare or neglected illnesses. The Ovation Pharmaceutical Company was established to focus on the patients and at the same time the development of drugs. He was able to differentiate his company from other biotech and pharmaceutical companies by focusing on the smaller diseases while the rest placed their interest in finding the next blockbuster.


Jeff Aronin has an in-depth understanding of sophisticated research methods, rare illnesses and the development of new medicines and bags an experience of 20 years. He is a leader full of compassion with a desire to serve others. Jeff Aronin’s, unmatched leadership skills, enable him to assemble groups of caring researchers in finding the cures for terminal illness rare medical conditions. He is enthusiastic about sharing his knowledge with younger entrepreneurs with a desire to make a positive change.


Lundbeck, a Danish healthcare pharmaceutical company in 2009, offered to buy the Ovation Company. It was finally purchased at $900, a company that was raised from scratch by Jeff Aronin. After the final closure of the purchase, Jeff Aronin was still given the position he had as the CEO which assisted in the transactions and flow of the business.